A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

Clinical trial NCT07181473 · RECRUITING

Trial details

NCT number: NCT07181473
Sponsor: Phrontline Biopharma
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Cancer (NSCLC)Prostate Cancer Esophageal Cancer Solid Tumor Malignancies

Start date: 2025-08-25
Primary completion: 2026-12-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.